Attorney General Weiser announces settlement with former COVID-19 test distributor after company used false advertising, overcharged Coloradans
June 10, 2026 (DENVER) — Attorney General Phil Weiser and a bipartisan coalition of 18 attorneys general today announced a $4.87 million settlement with GS Labs, a former COVID-19 rapid testing business, after their marketing and pricing was found to have violated the Colorado Consumer Protection Act.
Founded by 88Med, a medical diagnostics company, GS Labs offered rapid COVID-19 testing services during the pandemic and advertised test results with limited to no wait times, same day appointments, and no out-of-pocket expenses. Nearly all these claims were not only false but also preyed on vulnerable Coloradans during a time when public concern and fear was exceptionally high.
“The COVID-19 pandemic was a particularly hard time for many of us,” said Attorney General Weiser. “Preying on Coloradans is never tolerated, and to do so during such a uniquely difficult period is unconscionable. Our office will continue to hold bad actors accountable for such practices.”
GS Labs’ advertising and business practices were misleading and took advantage of Coloradans in numerous ways. First, as part of their marketing, GS Labs advertised a cash price for COVID-19 tests that exceeded the going market rate, sometimes as high as $380 per test or nearly $1,000 for multi-panel tests. This was done to secure higher payments from insurance providers and consumers who wanted to pay cash through a “cash discount program” offered by GS Labs. Second, the company promoted that their testing services would come with no out-of-pocket fees for insured consumers. Many consumers then learned that GS Labs charged an additional $49 administrative fee per test, contrary to the “no out-of-pocket expenses” promise. Finally, GS Labs guaranteed test results within three days, yet hundreds of thousands of consumers did not receive test results on time, with many often waiting well over a week. Consumers that received late results were neither given a discount nor a refund by GS Labs, despite the results being essentially useless.
GS Labs has ceased to offer COVID-19 rapid testing. If they were to resume these services, however, the settlement (PDF) prevents them from charging administrative fees, pricing more than the market rate, or charging consumers for late results. GS Labs will pay over $3.6 million in restitution. To determine one’s eligibility, consumers must complete a brief verification process, which is available on GS Labs’ website (opens new tab). All information used to verify a consumer’s identity will solely be used for that purpose and will not be saved, stored or shared. GS Labs will be contacting affected consumers via email to share more information about the restitution process. Finally, GS Labs will pay $1.25 million to the multistate group, of which Colorado will receive $23,601 to cover legal fees.
Joining the settlement alongside Colorado are the attorneys general of Alabama, Arizona, Illinois, Indiana, Iowa, Kansas, Massachusetts, Minnesota, Missouri, Nebraska, New Jersey, North Dakota, Ohio, Oregon, Pennsylvania, South Dakota, and Washington.
###
Media Contact:
Lawrence Pacheco
Chief Communications Officer
(720) 508-6553 office
lawrence.pacheco@coag.gov